Angiotensin II Receptor Blockers and Celiac Disease

Project Title Angiotensin II Receptor Blockers and Celiac Disease
Date Posted
Monday, January 16, 2012
Status
Complete
Deliverables
Description

Modular program-based one-time assessment of the risk of celiac disease associated with new use of angiotensin II receptor blockers (ARBs). Modular programs are adaptable standardized programs.

Medical Product
angiotensin II receptor blocker (ARB)
candesartan
eprosartan
irbesartan
losartan
olmesartan
telmisartan
valsartan
Health Outcome
celiac disease
Assessment Type
Exploratory Analyses
Study Type
Modular Program
Data Sources
Mini-Sentinel Distributed Dataset (MSDD)
FDA Center
CDER